First 'co-scientist' agent set to rapidly accelerate biomedical discoveries

Stanford researchers and startup Phylo released Biomni, a general-purpose biomedical AI agent that autonomously executes complex research tasks in minutes that normally take weeks. It integrates 68 specialized biomedical databases, 108 software packages, and 82 tools across 25 research domains, with real-world validation across causal gene prioritization, drug repurposing, rare-disease diagnosis, and microbiome analysis. Work published in Science.